HIGHLIGHTS
- who: Astrid Pechmann from the Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, Medical Center, University of Freiburg, University of Freiburg, Mathildenstr1, Freiburg, Germany have published the research work: Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study, in the Journal: (JOURNAL)
- what: The authors report data from the SMArtCARE registry of non-ambulant children with SMA type 2 and typen 3 under nusinersen treatment with a follow-up period of up to 38 months. The authors report data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.